These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23494371)

  • 1. A FLIPR assay for evaluating agonists and antagonists of GPCR heterodimers.
    Harvey JH; van Rijn RM; Whistler JL
    Methods Mol Biol; 2013; 995():43-54. PubMed ID: 23494371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord.
    Portoghese PS; Lunzer MM
    Eur J Pharmacol; 2003 Apr; 467(1-3):233-4. PubMed ID: 12706480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists.
    Bolling SF; Badhwar V; Schwartz CF; Oeltgen PR; Kilgore K; Su TP
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):476-81. PubMed ID: 11547297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of opioid antagonists on mu-, delta-, and kappa-opioid receptors with and without agonist pretreatment.
    Wang D; Sun X; Sadee W
    J Pharmacol Exp Ther; 2007 May; 321(2):544-52. PubMed ID: 17267582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of delta-opioid receptor subtypes in neuropathic pain.
    Mika J; Przewłocki R; Przewłocka B
    Eur J Pharmacol; 2001 Mar; 415(1):31-7. PubMed ID: 11245849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.
    Broom DC; Nitsche JF; Pintar JE; Rice KC; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2002 Nov; 303(2):723-9. PubMed ID: 12388657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of 7-benzylidenenaltrexone derivatives as a novel structural antitrichomonal lead compound.
    Kutsumura N; Nakajima R; Koyama Y; Miyata Y; Saitoh T; Yamamoto N; Iwata S; Fujii H; Nagase H
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4890-4892. PubMed ID: 26099536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
    Liu JG; Prather PL
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLIPR Calcium Mobilization Assays in GPCR Drug Discovery.
    Woszczek G; Fuerst E; Maguire TJA
    Methods Mol Biol; 2021; 2268():193-205. PubMed ID: 34085270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of a 7-benzylidenenaltrexone-preferring opioid receptor in porcine ileal submucosa.
    Townsend DW; Brown DR
    Br J Pharmacol; 2003 Oct; 140(4):691-700. PubMed ID: 14534152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ mobilization assays in GPCR drug discovery.
    Woszczek G; Fuerst E
    Methods Mol Biol; 2015; 1272():79-89. PubMed ID: 25563178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of selective agonists and positive allosteric modulators for µ- and δ-opioid receptors from a single high-throughput screen.
    Burford NT; Wehrman T; Bassoni D; O'Connell J; Banks M; Zhang L; Alt A
    J Biomol Screen; 2014 Oct; 19(9):1255-65. PubMed ID: 25047277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-Benzylidenenaltrexone (BNTX): a selective delta 1 opioid receptor antagonist in the mouse spinal cord.
    Sofuoglu M; Portoghese PS; Takemori AE
    Life Sci; 1993; 52(8):769-75. PubMed ID: 8383271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization of endogenously expressed delta-opioid receptors: no evidence for involvement of G protein-coupled receptor kinase 2.
    Willets J; Kelly E
    Eur J Pharmacol; 2001 Nov; 431(2):133-41. PubMed ID: 11728419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta-opioid receptor antagonists exhibit properties of partial delta-receptor agonists in isolated perfused heart.
    Maslov LN; Lasukova TV; Bespalova ZhD; Oldgen P; Rice KK; Nagase H
    Bull Exp Biol Med; 2004 Oct; 138(4):376-9. PubMed ID: 15665949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standard opioid agonists activate heteromeric opioid receptors: evidence for morphine and [d-Ala(2)-MePhe(4)-Glyol(5)]enkephalin as selective μ-δ agonists.
    Yekkirala AS; Kalyuzhny AE; Portoghese PS
    ACS Chem Neurosci; 2010 Feb; 1(2):146-54. PubMed ID: 22816017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
    Szekeres PG; Traynor JR
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Throughput Screening for Allosteric Modulators of GPCRs.
    Bertekap RL; Burford NT; Li Z; Alt A
    Methods Mol Biol; 2015; 1335():223-40. PubMed ID: 26260604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of the phosphoinositide pathway for signal transduction in changes in the sensitivity of delta-opiate receptors during diabetes mellitus.
    Agadjanov MI; Vartanian GS; Tadevosyan YV; Batikyan TB; Agadjanova EM
    Bull Exp Biol Med; 2004 Feb; 137(2):147-9. PubMed ID: 15273760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.